Cytostatic Injectables

Product description

Pharmaceutical development and production of oncological drug products are among the most important service areas of Aenova. Our highly trained team of experts operates state-of-the-art equipment to develop parenteral forms up to OEL category 5. – Formulation of anhydrous, viscous or alcohol-containing solutions– Process development for aseptic filling or terminal sterilization, N2 flushing– Development work is carried out in an FDA-approved GMP environment– Analytical development in dedicated lab– Packaging– Vials (1 - 250 ml)– Secondary packaging: sealed safety containers
Read more


Categories Finished Dosage FormsInjectables
Sales markets Western Europe; Eastern Europe; Asia; Australia; North America
Supplied from Germany

Products from other suppliers